BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Provectus Biopharmaceuticals Inc. 

7327 Oak Ridge Highway Suite B

Knoxville  Tennessee  37931  U.S.A.
Phone: 866-594-5999 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Provectus Biopharmaceuticals Inc. Data Presented At ESMO 2014 Congress Show Ablative, Bystander Effects Of PV-10 9/29/2014 11:43:12 AM
Provectus Biopharmaceuticals Inc.’ PV-10 Clinical Data On Melanoma Now Available For European Society For Medical Oncology 2014 Congress 9/24/2014 12:11:19 PM
Provectus Biopharmaceuticals Inc.’ Intralesional Pv-10 And Co-Inhibitory Blockade Data To Be Presented At SITC 29th Annual Meeting 9/23/2014 11:46:08 AM
Provectus Biopharmaceuticals Inc. Appoints Christopher Kaplan To Its Strategic Advisory Board 9/22/2014 9:23:01 AM
Provectus Biopharmaceuticals Inc. Signs Memorandum Of Understanding With Sinopharm-China State Institute Of Pharmaceutical Industry, And Sinopharm A-THINK Pharmaceutical Co., Ltd. 8/18/2014 8:03:01 AM
Provectus Biopharmaceuticals Inc. To Commence Series Of Quarterly Conference Calls On Thursday, August 7, 2014 8/6/2014 9:18:45 AM
Provectus Biopharmaceuticals Inc.’ PV-10 Clinical Data On The Treatment Of Melanoma To Be Presented At European Society For Medical Oncology 2014 Congress 7/23/2014 12:08:35 PM
Provectus Biopharmaceuticals Inc. Updates Shareholders In Its Annual CEO Letter 7/8/2014 11:19:16 AM
Provectus Biopharmaceuticals Inc. To Hold Conference Call Today To Detail Outline Of Phase 3 Clinical Trial Of PV-10 In Melanoma Treatment 6/19/2014 11:35:07 AM
Provectus Biopharmaceuticals Inc. To Discuss Outline Of Phase 3 Clinical Trial Of PV-10 To Treat Melanoma On Conference Call 6/12/2014 9:38:42 AM
12345678910...